Buy Semaglutide OXY-SEMA (5 mg) Oxypharma in Ukraine Semaglutide is an analogue of glucagon-like peptide 1 (GLP-1), with a sequence 94% identical to human GLP-1. Semaglutide acts as a GLP-1 receptor agonist that selectively binds and activates the GLP-1 receptor. It lowers blood glucose in a glucose-dependent manner — stimulating insulin secretion and reducing glucagon secretion when glucose runs high. The glucose-lowering mechanism also involves a slight delay in gastric emptying. During hypoglycaemia, semaglutide reduces insulin secretion and leaves glucagon secretion untouched. Semaglutide reduces body weight and fat mass through a general drop in appetite. Buy Semaglutide 5 mg Online – Indications for Use • Adjunct to diet and exercise, to improve glycaemic control in adults with type 2 diabetes mellitus • To reduce the risk of major adverse cardiovascular events in adults with type 2 diabetes mellitus and established cardiovascular disease Semaglutide 5 mg Dosage The starting dose of Semaglutide is 0.25 mg once weekly. After 4 weeks, the dose should be raised to 0.5 mg once a week. After at least 4 weeks on 0.5 mg once weekly, the dose can go up to 1 mg once weekly to improve glycaemic control further. Weekly doses above 1 mg are not recommended. Semaglutide is prescribed once a week at any time of day, with or without food. Injections are subcutaneous — into the abdomen, thigh or upper arm. The injection site may be changed without altering the dose. Semaglutide should not be given intravenously or intramuscularly. If needed, the day of the weekly dose can be shifted, provided at least 3 days (>72 hours) separate the two doses. After settling on a new day, keep to it week after week. Precautions Diabetic ketoacidosis: semaglutide should not be used in type 1 diabetes mellitus or for the treatment of diabetic ketoacidosis. Pancreatitis: if pancreatitis is suspected, stop semaglutide immediately — and if pancreatitis is confirmed, do not restart. Diabetic retinopathy: patients with diabetic retinopathy should be monitored. Use during pregnancy and lactation Semaglutide should not be used during pregnancy. If a patient wishes to become pregnant, semaglutide should be stopped at least 2 months before the planned pregnancy. Since a risk to a breastfed baby cannot be ruled out, semaglutide should not be used during breastfeeding. Interaction with other drugs Semaglutide slows gastric emptying and may affect the rate at which oral drugs taken alongside it are absorbed. Use with caution in patients taking oral medications that require rapid gastrointestinal absorption. Overdose In clinical studies, cases of overdose up to 4 mg at a time and up to 4 mg per week have been reported. The most commonly reported adverse reaction was nausea. There is no specific antidote for semaglutide overdose. In case of overdose, start appropriate supportive treatment based on the patient’s clinical signs and symptoms. Storage Store at 2 C to 8 C (in the refrigerator). Do not freeze. Keep out of the reach of children. Semaglutide 6 mg can be ordered online in Ukraine, Kyiv and other cities with cash on delivery. ECA fat burners, clenbuterol, T3, Semaglutide OXY-SEMA (5 mg) Oxypharma
Semaglutide OXY-SEMA (5 mg) OxyPharma
€0.00
Semaglutide OXY-SEMA (5 mg) OxyPharma — product information
Semaglutide is an analogue of glucagon-like peptide 1 (GLP-1), with 94% sequence identity to human GLP-1. It functions as a GLP-1 receptor agonist, binding selectively to the GLP-1 receptor and activating it. Blood glucose is lowered in a glucose-dependent fashion — insulin secretion is stimulated while glucagon secretion falls when blood glucose runs high. A slight delay in gastric emptying is part of the glucose-lowering mechanism too. During hypoglycaemia, semaglutide pulls insulin secretion back and leaves glucagon secretion alone. Body weight and body fat mass also drop through a general reduction in appetite.
Semaglutide 5 mg — indications for use
• Adjunct to diet and exercise to improve glycaemic control in adults with type 2 diabetes mellitus
• Reduction of risk of major adverse cardiovascular events in adults with type 2 diabetes mellitus and established cardiovascular disease
Semaglutide 5 mg — dosage
The starting dose of semaglutide is 0.25 mg once weekly. After 4 weeks, the dose should be raised to 0.5 mg once a week. After at least 4 weeks on 0.5 mg once-weekly dosing, the dose may be increased to 1 mg once weekly for further glycaemic benefit. Weekly doses above 1 mg are not recommended.
Semaglutide is given once a week at any time of day, with or without food. The injection goes subcutaneously into the abdomen, thigh or upper arm. The site can be changed without any dose adjustment. Semaglutide should not be administered intravenously or intramuscularly. The weekly dosing day can be shifted when needed — provided at least 3 days (>72 hours) sit between two doses. After a new day is chosen, dosing continues weekly from that point.
Precautions
Diabetic ketoacidosis. Semaglutide shouldn’t be used in type 1 diabetes mellitus, nor for the treatment of diabetic ketoacidosis.
Pancreatitis. If pancreatitis is suspected, semaglutide should be discontinued immediately. If pancreatitis is confirmed, do not restart.
Diabetic retinopathy. Patients with diabetic retinopathy need to be monitored.
Use during pregnancy and lactation
Semaglutide should not be used during pregnancy. For a patient planning a pregnancy, semaglutide should be discontinued at least 2 months before. Risk to a breastfed child cannot be excluded, so semaglutide should not be used during breastfeeding either.
Interaction with other drugs
Semaglutide slows gastric emptying and may affect the absorption rate of concurrently taken oral drugs. Use with caution in patients on oral medications that require fast gastrointestinal absorption.
Overdose
Clinical studies have reported overdoses up to 4 mg in a single administration and up to 4 mg per week. The most common adverse reaction was nausea. No specific antidote for semaglutide overdose exists. In the event of overdose, supportive treatment is started based on the patient’s clinical presentation.
Storage
Store at temperatures between 2 C and 8 C (in the refrigerator). Do not freeze. Keep out of reach of children.
ECA fat burners, clenbuterol, T3, Semaglutide OXY-SEMA (5 mg) Oxypharma
Out of stock
Semaglutide at 5 mg per vial covers a middle stretch of the standard titration — several weeks at starter doses, or two to three weeks at the 2 mg range. GLP-1 receptor agonism slows gastric emptying and reduces appetite signalling via central pathways. Standard titration starts at 0.25 mg weekly for a month, climbing in similar steps toward a 2.4 mg maintenance for weight management. Reconstitute with 1–2 ml bacteriostatic water. Weekly sub-cut injection, rotating between abdomen, thigh and upper arm.
| Peptide | Semaglutide |
| Vial content | 5 mg lyophilised |
| Lab | OxyPharma |
| Receptor target | GLP-1 receptor agonist |
| Weekly titration | 0.25 mg climbing slowly to 2.4 mg |
| Reconstitution | Bacteriostatic water, 2 ml typical |
| Route | Subcutaneous |
| Storage | 2–8 °C in the fridge |
Semaglutide at 5 mg per vial — a mid-range supply for anyone running the GLP-1 titration in the standard pattern.
Weekly doses typically sit at 0.5–1.0 mg at this stage, reached after the initial 0.25 mg starter month. The peptide suppresses appetite centrally and slows gastric emptying. A 5 mg vial generally covers five to ten weeks of use depending on where in the climb the user happens to sit.
Frequently Asked Questions
How long does a 5 mg Semaglutide vial last?
A 5 mg vial covers roughly 4–6 weeks at mid-range doses after full titration. Weekly jumps step up from 0.25 mg to 2.4 mg over several months.
How quickly does weight start dropping on Semaglutide?
Appetite usually drops in the first week on Semaglutide, with steady weight loss normally setting in by the end of week two or three.
How often is Semaglutide injected per week?
Users begin at the lowest dose and raise it slowly: starts at 0.25 mg weekly, titrated up to 2.4 mg, continued for several months of weekly dosing.
What are the side effects of Semaglutide?
A 5 mg vial covers roughly 5–10 weeks for most users, depending on where they sit in the titration. Starting dose stays at 0.25 mg weekly.
Can Semaglutide be stopped suddenly after months?
Users typically taper down to avoid an appetite rebound and sharp weight regain. A gradual exit over several weeks is kinder on the body.
Reviews
There are no reviews yet